Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 41

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 41
---
’ solutions are technology-driven platforms that rely on innovation to remain competitive. The process
of developing new technologies and products is complex, and we have built and seek to further develop our own technology using the latest
in AI and machine learning, cloud-based technologies and other tools to differentiate our products and technologies. In addition,
our dedication to incorporating technological advancements into our AI platforms requires significant financial and personnel resources
and talent. Our development efforts with respect to these initiatives could distract management from current operations and could divert
capital and other resources from other growth initiatives important to our business. We operate in an industry experiencing rapid technological
change and frequent product introductions. We may not be able to make technological improvements as quickly as demanded by our customers,
or we may not be able to accurately predict the demand or growth of its technological investments, which could harm its ability to attract
customers and have a material and adverse effect on its business, results of operations, financial condition and future prospects. In
addition, we may not be able to effectively implement new technology-driven products and services as quickly as our competitors or be
successful in marketing these products and services to potential customers. If we are unable to successfully and timely innovate, we could
experience reputational damage and decreased demand for our AI platforms and other products and technologies and our growth, business,
results of operations, financial condition and future prospects could be materially and adversely affected.

Renovaro
Cube’s and BioSymetrics’ AI platform and other related products may become obsolete due to fast growing technological innovations
or the entry of competitors with more financial and brand power.

AI is a fast-growing industry
and Renovaro Cube and BioSymetrics must successfully adapt and manage technological advancements in AI and AI-related markets,
as well as effectively compete with the emergence of additional competitors in the AI industry in order to maintain and grow AI business
and products. Thus, the success of Renovaro Cube’s or BioSymetrics’ AI platform, other products and business depends in large
part on their ability to keep pace with rapid technological changes in the development and implementation of AI products. For example,
the development of groundbreaking technological innovations in AI, or innovations that would render AI obsolete, would harm Renovaro Cube’s
or BioSymetrics’ business and make its platform or other products less durable. Further, the entry of competitors into the AI market
that have more financial and brand power could cause Renovaro Cube’s or BioSymetrics’ share of the market to be significantly